Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

Core Viewpoint - Montagu and Kohlberg have entered into a definitive agreement to acquire Teleflex Medical OEM for $1.5 billion in a carve-out transaction from Teleflex Incorporated [1] Company Overview - Teleflex Medical OEM has over 40 years of experience in developing and supplying custom-engineered interventional catheter components, surgical fibers, and sutures, serving fast-growing treatment areas such as structural heart, neurovascular, electrophysiology, and urology [2] - The company operates seven state-of-the-art facilities across the U.S., Mexico, and Ireland, leveraging complex extrusion expertise and a vertically integrated operating model to support a blue-chip customer base in the medical device sector [2][6] Transaction Details - The transaction is expected to close in the second half of 2026, subject to regulatory approvals and other closing conditions, after which Teleflex Medical OEM will operate as an independent global contract developer and manufacturer [3] - Greg Stotts, currently the President and General Manager of Teleflex, will become the CEO post-transaction, bringing over 30 years of industry experience [3] Strategic Focus - The acquisition aims to accelerate investment in innovation, quality systems, and capacity while maintaining reliability and engineering depth for customers [4] - Montagu and Kohlberg plan to leverage their expertise in carve-out transactions and value creation to support Teleflex Medical OEM's growth and expansion of its customer base [4][5] Market Position - Teleflex Medical OEM is recognized as a leading strategic supplier in the global medtech value chain, known for its engineering support, reliability, and quality [5] - The company is positioned to create long-term, mutually beneficial partnerships with customers, addressing the increasing pressure on medical device companies to optimize portfolios and consolidate supply chains [5]